vimarsana.com

Latest Breaking News On - Apellis pharmaceuticals price performance - Page 1 : vimarsana.com

Frazier Life Sciences Management L P Acquires 271,122 Shares of Apellis Pharmaceuticals, Inc (NASDAQ:APLS)

Frazier Life Sciences Management L.P. lifted its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 44.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 885,165 shares of the company’s stock after acquiring an additional 271,122 shares during the […]

Apellis Pharmaceuticals (NASDAQ:APLS) PT Lowered to $48 00 at Wells Fargo & Company

Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price trimmed by Wells Fargo & Company from $57.00 to $48.00 in a research note released on Thursday morning, Benzinga reports. The brokerage currently has an equal weight rating on the stock. Other analysts also recently issued reports about the stock. Wedbush dropped their price objective […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.